Premier Health of America Inc. (V:PHA)
Business Focus: Online Services (NEC)
| Sector: Technology | Industry: Online Services |
| See Regulatory Filings on SEDAR | |
| Company Contact | |
| Address: | 1114 Cure-Labelle Boulevard, Suite 1 BLAINVILLE QC J7C 2M9 |
| Tel: | N/A |
| Website: | https://www.premierhealthgroup.ca |
| IR: | See website |
| Key People | ||
| Martin Legault President, Chief Executive Officer, Director | Sylvain Charbonneauc Chief Financial Officer | Jean-Robert Pronovost Director, Vice President Corporate Development | Gilles Seguin Director, Corporate Secretary |
| Business Overview |
| Premier Health of America Inc. is a Canada-based company that is engaged in the health care services business. The Company has developed a healthcare services platform that provides a range of staffing and outsourced services solutions for healthcare needs to governments, corporations and individuals. It provides services through its PSweb platform, which is the healthcare services sector's digital transformation platform to provide patients with care services. The Company covers multiple segments, including emergency rooms and operating rooms. |
| Financial Overview |
| For the six months ended 31 March 2022, Premier Health of America Inc revenues increased 19% to C$36M. Net loss totaled C$459K vs. income of C$772K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Administrative Expenses increase of 51% to C$8.4M (expense), Fair Value Adjustments on Other Assets increase from C$0K to C$157K (expense). |
| Employees: | 186 as of Sep 30, 2020 |
| Reporting Currency: | Canadian Dollars |
| Enterprise value: | $36.98M as of Mar 31, 2022 |
| Annual revenue (TTM): | $72.26M as of Mar 31, 2022 |
| EBITDA (TTM): | $4.94M as of Mar 31, 2022 |
| Net annual income (TTM): | -$0.50M as of Mar 31, 2022 |
| Free cash flow (TTM): | $3.14M as of Mar 31, 2022 |
| Net Debt Last Fiscal Year: | $5.73M as of Mar 31, 2022 |
| Shares outstanding: | 55,840,331 as of May 18, 2022 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
US Quotes Data provided by IEX. Company fundamental and price data sourced from © Refinitiv. Click for restrictions. © Refinitiv. All rights reserved. Republication or redistribution of Refinitiv, including by framing or similar means, is prohibited without the prior written consent of Refinitiv. Refinitiv is not liable for any errors or delays in Refinitiv content, or for any actions taken in reliance on such content.
Interactive technical study charts by TradingView. Copyright © 2022 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.